162 related articles for article (PubMed ID: 21330458)
21. Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
Han NY; Park BJ; Yang KS; Kim MJ; Sung DJ; Sim KC; Cho SB
AJR Am J Roentgenol; 2017 Nov; 209(5):1039-1045. PubMed ID: 28813196
[TBL] [Abstract][Full Text] [Related]
22. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice.
Knitter S; Duwe G; Beierle AS; Pesthy S; Ritschl PV; Hillebrandt KH; Arnold A; Malinka T; Modest DP; Bahra M; Pratschke J; Sauer IM; Schmelzle M; Andreou A
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497474
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S; Jabbour EJ; Mohty M
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
[TBL] [Abstract][Full Text] [Related]
25. Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report.
Bernichon E; Daguenet E; Molla C; Cornillon J; Lejeune C; Casteillo F; Guyotat D; Tavernier E
Curr Res Transl Med; 2018 Nov; 66(4):107-110. PubMed ID: 29519713
[TBL] [Abstract][Full Text] [Related]
26. Extravasated platelet aggregation in the livers of rats with drug‑induced hepatic sinusoidal obstruction syndrome.
Hirata M; Tajima H; Miyashita T; Miyata T; Nakanuma S; Makino I; Hayashi H; Oyama K; Takamura H; Ninomiya I; Fushida S; Nakata H; Iseki S; Harada S; Wakayama T; Ohta T
Mol Med Rep; 2017 May; 15(5):3147-3152. PubMed ID: 28358421
[TBL] [Abstract][Full Text] [Related]
27. The role of hepatic sinusoidal obstruction in the pathogenesis of the hepatic involvement in HELLP syndrome: Exploring the literature.
von Salmuth V; van der Heiden Y; Bekkers I; van Runnard Heimel P; Spaanderman MA; Peeters LL; Koek GH
Pregnancy Hypertens; 2020 Jan; 19():37-43. PubMed ID: 31877439
[TBL] [Abstract][Full Text] [Related]
28. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
[TBL] [Abstract][Full Text] [Related]
29. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
[TBL] [Abstract][Full Text] [Related]
30. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
[TBL] [Abstract][Full Text] [Related]
31. A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats.
Conotte R; Colet JM
Toxicol Appl Pharmacol; 2014 Apr; 276(2):147-56. PubMed ID: 24582690
[TBL] [Abstract][Full Text] [Related]
32. Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver.
Narita M; Hatano E; Tamaki N; Yamanaka K; Yanagida A; Nagata H; Asechi H; Takada Y; Ikai I; Uemoto S
J Gastroenterol Hepatol; 2009 Jun; 24(6):1051-7. PubMed ID: 19638085
[TBL] [Abstract][Full Text] [Related]
33. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
[TBL] [Abstract][Full Text] [Related]
34. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
[TBL] [Abstract][Full Text] [Related]
35. Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.
Kim MJ; Han SW; Lee DW; Cha Y; Lee KH; Kim TY; Oh DY; Kim SH; Im SA; Bang YJ; Kim TY
Cancer Res Treat; 2016 Jul; 48(3):990-7. PubMed ID: 26790967
[TBL] [Abstract][Full Text] [Related]
36. Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma.
Sakumura M; Tajiri K; Miwa S; Nagata K; Kawai K; Miyazono T; Arita K; Wada A; Murakami J; Sugiyama T
Intern Med; 2017; 56(4):395-400. PubMed ID: 28202860
[TBL] [Abstract][Full Text] [Related]
37. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
[TBL] [Abstract][Full Text] [Related]
39. Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome.
Han NY; Park BJ; Kim MJ; Sung DJ; Cho SB
Radiology; 2015 Sep; 276(3):766-74. PubMed ID: 25822471
[TBL] [Abstract][Full Text] [Related]
40. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
